NEW YORK (GenomeWeb News) – A federal court judge has granted Illumina's motion for summary judgment that its sequencing technology does not infringe three Life Technologies patents.

In the decision handed down on Wednesday, Judge Cathy Ann Bencivengo of the US District Court for the Southern District of California said that Illumina does not infringe US Patent Nos. 5,616,478; 5,958,698; and 6,001,568 held by Life Technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.